We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$140M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Carrier Global
CARR
|
+$94.7M |
| 5 |
Otis Worldwide
OTIS
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$47.8M |
| 2 |
Abbott
ABT
|
+$25.1M |
| 3 |
Colgate-Palmolive
CL
|
+$24.3M |
| 4 |
Hormel Foods
HRL
|
+$23.2M |
| 5 |
Walmart Inc
WMT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
BridgeBio Pharma
BBIO
$16.5B
| $955K | 0.01% |
29,292
+7,894
| +37% | +$240K |
|
727
Ciena
CIEN
$55.3B
| $953K | 0.01% |
17,600
+5,646
| +47% | +$281K |
|
728
NovoCure
NVCR
$2.04B
| $952K | 0.01% |
16,050
-2,654
| -14% | -$175K |
|
729
First Industrial Realty Trust
FR
$8.88B
| $941K | 0.01% |
24,472
-2,029
| -8% | -$74.2K |
|
|
COR
730
DELISTED
Coresite Realty Corporation
COR
| $939K | 0.01% |
7,755
+2,072
| +36% | +$249K |
|
731
PTC Therapeutics
PTCT
$6.37B
| $936K | 0.01% |
18,446
+6,413
| +53% | +$315K |
|
|
MASI
732
DELISTED
Masimo
MASI
| $934K | 0.01% |
4,098
+1,405
| +52% | +$308K |
|
733
Royal Caribbean
RCL
$78.7B
| $927K | 0.01% |
18,420
-17,758
| -49% | -$804K |
|
|
ACC
734
DELISTED
American Campus Communities, Inc.
ACC
| $927K | 0.01% |
26,510
+5,750
| +28% | +$191K |
|
735
Americold
COLD
$4.09B
| $918K | ﹤0.01% |
25,285
+3,405
| +16% | +$116K |
|
|
CCXI
736
DELISTED
ChemoCentryx, Inc.
CCXI
| $916K | ﹤0.01% |
15,928
+5,521
| +53% | +$300K |
|
737
AGNC Investment
AGNC
$12.3B
| $913K | ﹤0.01% |
70,766
+8,925
| +14% | +$112K |
|
738
Medpace
MEDP
$16.8B
| $913K | ﹤0.01% |
9,812
+2,789
| +40% | +$237K |
|
739
Pultegroup
PHM
$24.5B
| $912K | ﹤0.01% |
26,798
-14,877
| -36% | -$447K |
|
740
PTC
PTC
$13.7B
| $909K | ﹤0.01% |
11,679
+3,960
| +51% | +$281K |
|
741
Markel Group
MKL
$25B
| $907K | ﹤0.01% |
983
+105
| +12% | +$95.4K |
|
|
DAY
742
DELISTED
Dayforce
DAY
| $903K | ﹤0.01% |
11,387
+3,906
| +52% | +$251K |
|
743
HealthEquity
HQY
$7.91B
| $902K | ﹤0.01% |
15,367
+7,432
| +94% | +$411K |
|
744
Gaming and Leisure Properties
GLPI
$12.8B
| $894K | ﹤0.01% |
25,831
+2,541
| +11% | +$79.2K |
|
745
Campbell Soup
CPB
$6.51B
| $892K | ﹤0.01% |
17,980
+3,083
| +21% | +$153K |
|
746
Glacier Bancorp
GBCI
$6.55B
| $889K | ﹤0.01% |
25,198
+13,322
| +112% | +$494K |
|
747
Maximus
MMS
$3.14B
| $886K | ﹤0.01% |
12,576
+6,308
| +101% | +$424K |
|
748
Snap
SNAP
$7.32B
| $886K | ﹤0.01% |
37,715
+8,290
| +28% | +$147K |
|
749
Wynn Resorts
WYNN
$10.1B
| $886K | ﹤0.01% |
11,892
+3,029
| +34% | +$243K |
|
750
Tetra Tech
TTEK
$8.23B
| $878K | ﹤0.01% |
55,455
+28,620
| +107% | +$435K |
|
Similar funds
ProShare Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.
- ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
- ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
- ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
- ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
- ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
- ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
- ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.
Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.